Pirlimycin
Systematic (IUPAC) name | |
---|---|
Methyl(2S-cis)-7-chloro-6,7,8-trideoxy-6[[(4-ethyl-2-piperidinyl)
carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside | |
Clinical data | |
Routes of administration | Intramammary |
Identifiers | |
CAS Number | 79548-73-5 |
ATCvet code | QJ51FF90(WHO) |
ChemSpider | 138508 |
UNII | LM19JT6G5K |
KEGG | D08391 |
ChEMBL | CHEMBL1652611 |
Chemical data | |
Formula | C17H31ClN2O5S |
Molar mass | 410.164 g/mol |
| |
| |
(what is this?) (verify) |
Pirlimycin hydrochloride belongs to the lincosamide class of antimicrobials. Under the trade name Pirsue,[1] it is used in the treatment of mastitis in cattle.
Activity
Pirlimycin is active against Gram-positive bacteria, specifically Staphylococcus aureus and coagulase negative species of Staphylococcus and Streptococcus. It has no activity against Gram-negative bacteria.[2]
Mechanism of action
It is bacteriostatic and acts by inhibiting bacterial protein synthesis via binding with the 50S subunit of the ribosome.
References
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.